Immuncontraception Reversibility Test of Goat Zona Pellucida-3 (gZP3) on Mice (Mus musculus)
AbstractThe aim of this study was to prove the reversibility of gZP3 protein on mice as an animal model. Treatment group of mice (Mus musculus) were immunized with 40 ug goat zona pellucida-3 (gZP3) as an anti fertility agent. Control group of mice were injected only with physiologic solution. The mice were injected three times, the first injection as an immunization. The second and third injected as a booster with 14 days interval. The first injection, gZP3 suspension was diluted in complete FreundÃ¢â‚¬â„¢s adjuvant (CFA). The boosters, gZP3 suspension was diluted in incomplete FreundÃ¢â‚¬â„¢s adjuvant (IFA) 1:1 (v/v). Blood samples were collected before immunization, seven days after the second booster and at the time of parturition. Seven days after the last injection, the mice were mated, and the parturition was observed after that. The result showed that antibody titer of immunized mice serum was increasing (P < 0.05) seven days after immunization, and decreasing (P > 0.05) after parturition compared to antibody titer of serum before immunization. Dot blotting analysis showed that gZP3 protein could recognize gZP3 antibody of the immunized mice. Protein of gZP3 as an immunocontraceptive substance was reversible in 91.60 + 4.90 days. This reversibility was longer (P < 0.05) compared to control mice i.e. 26.50 + 4.30 days.
Key words: immunocontraception, goat zona pellucida-3, reversibility, mice, animal model, gZP3 antibody
Starting Vol. 25 No. 1, HAYATI J Biosci article's license is CC-BY. This license lets others distribute, remix, tweak, and build upon author's work, even commercially, as long as they credit the original creation.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).